Q2 2020 CytomX Therapeutics Inc Earnings Call Transcript
Good day, ladies and gentlemen. Welcome to the CytomX Therapeutics Second Quarter 2020 Financials Conference Call. (Operator Instructions) As a reminder, this call may be recorded. I will now introduce your host for today's conference call, Christopher Keenan, Vice President of Investor Relations. Chris, please go ahead.
Thank you, Valerie. Good afternoon, and thank you for joining us. Earlier today, we issued a press release that includes a summary of our recent progress and second quarter 2020 financial results. This press release and a recording of this call can be found under the Investors and News section of our website at cytomx.com. With me today are CytomX President, Chief Executive Officer and Chairman, Dr. Sean McCarthy; and CytomX's Chief Financial Officer, Carlos Campoy.
During today's call, we will be making forward-looking statements. Because forward-looking statements relate to the future, they are subject to inherent uncertainties and risks,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |